RSS-Feed abonnieren

DOI: 10.1055/s-0042-1757381
Evaluation of Tetrofosmin Cold Kit Fractionation Using Alternative New Method of Quality Control for Testing Radiochemical Purity
Autor*innen
Funding None.
Abstract
Objective The aim of this study is to establish a method for the fractionation of tetrofosmin cold kit under different storage conditions and to optimize an alternate chromatography method from the reference method to test radiochemical purity (RCP).
Materials and Methods Tetrofosmin cold kit vial was fractionated aseptically in six equal fractions and stored in vials and syringes. To test the stability of the reconstituted solution for a longer duration, the mother vials and syringes were stored at two different temperatures, that is, at 4°C and at −20°C till further used. Radiolabeling of fractionated tetrofosmin was performed as per the standard labeling protocol. Radionuclide purity, radioassay, and pH were tested. Radiolabeling efficiency and RCP were determined by paper chromatography.
Results Radionuclide purity of eluate was greater than 99.9%. The pH of technetium-99m (Tc-99m) eluate and Tc-99m tetrofosmin was between 4.5–7.5 and 7.5–9.5, respectively. The deviation in the radioactivity during all measurements was less than 1%. The kits fractioned in glass vials resulted in higher radiolabeling yield and RCP as compared with kits fractionated in syringes. The RCP of glass vial versus syringe was observed to be greater than 95 versus 90% and 95 versus 80% at −20°C and 4°C, respectively.
Conclusion Tetrofosmin kit can be used in a cost-effective manner by fractionation. One tetrofosmin vial can be used in six fractions for up to 15 days when stored at −20°C and 4°C freezer temperature. The alternative method to check the RCP of Tc-99m tetrofosmin is safer and less time consuming as compared with the reference method.
Registration Number
Institutional Ethics committee (Ref No HIMS/RC/2015/1056, dated 27/07/2015).
Publikationsverlauf
Artikel online veröffentlicht:
14. September 2022
© 2022. World Association of Radiopharmaceutical and Molecular Therapy (WARMTH). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Klain M, Maurea S, Cuocolo A. et al. Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans. Eur J Nucl Med 1996; 23 (12) 1568-1574
- 2 Bhatia N, Dhingra VK, Kumari S, Dhawan DK, Chadha VD. Efficacy of dual use of Tc-99m-pertechnetate and Tc-99m tetrofosmin scintigraphy for the assessment of thyroid nodules. Journal of Medical Imaging and Radiation Oncology 2020; 64 (02) 189-196
- 3 Lazarus C, Palmer AM, Hesslewood SR. Radiopharmaceutical kit modification. Nucl Med Commun 1998; 19 (07) 613-614
- 4 Penglis S, Tsopelas C. 99Tcm-tetrofosmin: evaluation of fractionated cold kits and two new methods of quality control. Nucl Med Commun 2000; 21 (05) 469-472
- 5 Bayomy T, Moustafa H, Pant G. Tetrofosmin cold kit fractionation, a chromatographic study to assess long fractionation terms and different storage conditions. J Nucl Med 2012; 53 (Suppl. 01) 1756
- 6 Eggert LA, Dick MD, Mahoney DW, Olson JP, Werner GL, Hung JC. A rapid radiochemical purity testing method for 99mTc-tetrofosmin. J Nucl Med Technol 2010; 38 (02) 81-84
- 7 Hammes R, Joas LA, Kirschling TE. et al. A better method of quality control for 99mTc-tetrofosmin. J Nucl Med Technol 2004; 32 (02) 72-78
- 8 Hammermaier A, Reich E, Bögl W. Chemical, radiochemical, and radionuclide purity of eluates from different commercial fission 99Mo/99mTc generators. Eur J Nucl Med 1986; 12 (01) 41-46
- 9 Amin KC, Patel S, Doke A, Saha GB. An alternative method for determining the radiochemical purity of 99mTc-tetrofosmin. J Nucl Med Technol 2011; 39 (01) 51-54
- 10 Geyer MC, Zimmer M, Spies WG, Spies SM, Hendel RC. Rapid quality control of Technetium-99m-tetrofosmin: comparison of miniaturised and standard chromatography systems. J Nucl Med Technol 1995; 23: 186-189
- 11 Cagnolini A, Whitener D, Jurisson S. Comparison of the kit performance of three 99mTc myocardial perfusion agents. Nucl Med Biol 1998; 25 (04) 435-439

